SEC Tracker
Get the app

BioNexus Gene Lab BGLC

BioNexus Gene Lab: signs a material agreement, sells unregistered shares and reports a change in control

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)
  • Reports a change in control (5.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when BioNexus Gene Lab files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8071 and related industry codes: the same peer list as the financial tables.

  1. Aclarion ACON public float $4M, Jun 30, 2025
  2. Advanced Biomed ADVB public float $3M, Dec 31, 2025
  3. Ludwig Enterprises LUDG public float $10M, Jun 30, 2025
  4. CapForce CFOR public float $12M, Jun 30, 2025
  5. American Shared Hospital Services AMS public float $12M, Jun 30, 2025